¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Narcotic antagonist treatment"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • narcotic antagonist
    ¸¶¾à´ëÇ×Á¦
  • narcotic
    1. ¸¶¾à- 2. ¸¶¾à
  • narcotic abuse
    ¸¶¾à³²¿ë
  • narcotic analgesic
    ¸¶¾à¼ºÁøÅëÁ¦
  • narcotic dependence
    ¸¶¾àÀÇÁ¸
  • narcotic drug
    ¸¶¾à
  • narcotic intoxication
    ¸¶¾àÁßµ¶
  • narcotic withdrawal
    ¸¶¾à±Ý´Ü
  • antagonist
    1. ´ëÇ×Á¦, ±æÇ×Á¦ 2. ´ëÇ×±Ù
  • adrenergic antagonist
    ¾Æµå·¹³¯¸°´ëÇ×Á¦, ¾Æµå·¹³¯¸°±æÇ×Á¦
  • competitive antagonist
    °æÀï´ëÇ×Á¦
  • contralateral antagonist
    ¹Ý´ëÂÊ´ëÇ×±Ù
  • direct antagonist
    Á÷Á¢´ëÇ×±Ù
  • dopaminergic antagonist
    µµÆÄ¹Î´ëÇ×Á¦, µµÆÄ¹Î±æÇ×Á¦
  • muscarinic antagonist
    ¹«½ºÄ«¸°´ëÇ×Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antagonist
    1.´ëÇ×Á¦, ±æÇ×Á¦, 2.´ëÇ×±Ù
  • narcotic intoxication
    ¸¶¾àÁßµ¶
  • narcotic
    ¸¶¾à, ¸¶¾à-
  • narcotic withdrawal
    ¸¶¾à±Ý´Ü
  • self-treatment
    ÀÚ°¡Ä¡·á
  • treatment
    Ä¡·á, óġ
  • conservative treatment
    º¸Á¸Ä¡·á
  • dietetic treatment
    À½½ÄÄ¡·á
  • drug treatment
    ¾à¹°Ä¡·á
  • local treatment
    ±¹¼ÒÄ¡·á
  • mass treatment
    Áý´ÜÄ¡·á
  • occlusive treatment
    °¡¸²Ä¡·á
  • palliative treatment
    ¿ÏÈ­Ä¡·á, °í½ÄÄ¡·á
  • preventive treatment
    ¿¹¹æÄ¡·á
  • psychoanalytic treatment
    Á¤½ÅºÐ¼®Ä¡·á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • narcotic antagonist
    ¸¶¾à´ëÇ×Á¦
  • narcotic abuse
    ¸¶¾à³²¿ë
  • narcotic analgesic
    ¸¶¾à¼ºÁøÅëÁ¦
  • narcotic dependence
    ¸¶¾àÀÇÁ¸
  • narcotic drug
    ¸¶¾à
  • narcotic intoxication
    ¸¶¾àÁßµ¶
  • narcotic
    ¸¶¾à-, ¸¶Ã뼺-, ¸¶Ãë¾à
  • narcotic withdrawal
    ¸¶¾à±Ý´Ü
  • antagonist
    ´ëÇ×Á¦, ¸Â¹öÆÀÁ¦
  • adrenergic antagonist
    ¾Æµå·¹³¯¸°´ëÇ×Á¦
  • competitive antagonist
    °æÀï´ëÇ×¹°Áú
  • contralateral antagonist
    ¹Ý´ëÂÊ´ëÇ×±Ù
  • direct antagonist
    Á÷Á¢´ëÇ×±Ù
  • dopaminergic antagonist
    µµÆÄ¹Î´ëÇ×Á¦, µµÆÄ¹Î¸Â¹öÆÀÁ¦
  • ipsilateral antagonist
    °°ÀºÂÊ´ëÇ×±Ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • H2 receptor antagonist
    H2 ¼ö¿ëü ±æÇ×Á¦µé
  • alpha-adrenal receptor antagonist
    ¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
  • alpha-adrenergic antagonist
    ¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
  • androgen antagonist
    ³²¼ºÈ£¸£¸ó ±æÇ×Á¦
  • antagonist
    ±æÇ×Á¦
  • antagonist
    ±æÇ×Á¦(ÑÏù÷ð¥)
  • antagonist
    ±æÇ×Á¦, ±æÇ×¹°Áú, ±æÇ×±Ù, ±æÇ×¾à.
  • heavy metal antagonist
    Á߱ݼӱæÇ×¾à(̡˻ËÛ˻̰Ëâ).
  • heavy metal antagonist
    Á߱ݼӱæÇ×¾à(ñìÐÝáÕÑÏù÷å·).
  • Calots treatment
    Ä®·Î¿ä¹ý.
  • Carrels treatment
    Ä«·¼¿ä¹ý.
  • Castellanis treatment
    Ä«½ºÅÚ¶ó´Ï¿ä¹ý.
  • Co-Tuis treatment
    ÄÚÅõÀÌ¿ä¹ý.
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • acoustic treatment
    ÈíÀ½Ã³¸®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • narcotic antagonist
    ¸¶¾à±æÇ×Á¦.
  • blockade narcotic
    ¸¶¾à¼º Â÷´Ü.
  • narcotic
    ¸¶ÃëÀÇ,¸¶ÃëÁ¦
  • narcotic =anesthetic
    ¸¶¾à(ئå·)ÀÇ, ¸¶Ã뼺(ئö­àõ)ÀÇ, ¸¶Ãë¾à.
  • narcotic abuse
  • narcotic addiction
  • narcotic analgesic
    ¸¶¾à¼º ÁøÅëÁ¦.
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü<ºÀ¼â>.
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü.
  • narcotic dependence
  • narcotic dermopathy
    ¸¶¾à¼ºÇǺκ´
  • narcotic drug
    ¸¶¾à(ئå·).
  • narcotic intoxication
  • narcotic lung
    ¸¶¾à¼º ÆóÀå(ئå·àõ øËíó)
  • narcotic withdrawal
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blanket mass treatment
    Àü¿øÁý´ÜÄ¡·á¹ý
  • mass treatment
    Áý´ÜÄ¡·á
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • narcotic drug
    ¸¶¾à(ئå·)
  • Briggs-Haldane treatment
    ºê¸¯½º-ÇÒµ§ ó¸®(ô¥×â)
  • Michaelis-Menten treatment
    ¹ÌŰ¿¤¸®½º-¸àÅ٠ó¸®(ô¥×â)
  • antagonist
    ±æÇ×Á¦(ÑÏù÷ð¥)
  • cholinergic antagonist
    Äݸ°±æÇ×Á¦(ÑÏù÷ð¥)
  • gibberellin antagonist
    Áö¹ö·¼¸° ±æÇ×Á¦(ÑÏù÷ð¥)
  • irreversible antagonist
    ºñ°¡¿ª ±æÇ×Á¦(ުʦæ½ÑÏù÷ð¥)
  • metabolic antagonist
    ´ë»ç¼º ±æÇ×Á¦(ÓÛÞóàõÑÏùòð¥))
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antagonist
    ±æÇ×Á¦, ±æÇ×¹°Áú
  • narcotic
    ¸¶¾à(ÀÇ), ¸¶Ã뼺ÀÇ, ¸¶Ãë¾à
  • narcotic addiction
    ¸¶¾àÁßµ¶
  • narcotic analgesic
    ¸¶¾à¼ºÁøÅëÁ¦
  • narcotic drug
    ¸¶¾à
  • narcotic intoxication
    ¸¶¾àÁßµ¶
  • local treatment
    ±¹¼ÒÄ¡·á, ±¹¼Ò¿ä¹ý
  • palliative treatment
    °í½ÄÀûÄ¡·á
  • radical treatment
    ±ÙÄ¡¿ä¹ý
  • supportive treatment
    ÁöÁö¿ä¹ý
  • surgical treatment
    ¿Ü°ú¿ä¹ý
  • treatment
    Ä¡·á, ¿ä¹ý, ó¸®, óġ
  • treatment of choice
    ÃÖÀû¿ä¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
narco narcotic, narcotic addict, drug enforcement agent
antag antagonist
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
FAA folic acid antagonist; formaldehyde, acetic acid, alcohol
NA   1) Narcotic Anonymous
  2) Nomina Anatomica; Anatomic Nomenclature; ÇØºÎÇÐ ¸í¸í¹ý...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Ant Antagonist
CA calcium antagonist
GnRH-A GnRH antagonist
H2-RA Histamine-2 receptor antagonist
IL 1ra IL 1 receptor antagonist
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • narcotic antagonist
    ¸¶¾à ±æÇ×Á¦
  • narcotic
    ¸¶¾àÀÇ, ¸¶ÃëÀÇ, ¸¶Ã뼺ÀÇ, ¸¶Ãë¾à, ¸¶¾à, Á¤½Å¸¶¾à
    µ¿ÀǾî=anesthetic.
  • narcotic addiction
    ¸¶¾à Áßµ¶
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü
  • narcotic drug
    ¸¶¾à
    ¸ð¸£ÇÉ, ÄÚÄ«ÀÎ, ¾ÆÆí µî°ú ±× À¯µµÃ¼·Î¼­ ¹Ì·®À¸·Î °­·ÂÇÑ ÁøÅë ÀÛ¿ë°ú ¸¶Ãë ÀÛ¿ëÀ» Áö´Ï¸ç °è¼Ó »ç¿ëÇÏ¸é ½À°ü¼º°ú Ž´Ð¼ºÀÌ »ý±â°Ô ÇÏ´Â ¹°Áú. »ç¿ëÀ» Áß´ÜÇÏ¸é °Ý·ÄÇÑ ±Ý´Ü Áõ¼¼¸¦ ÀÏÀ¸ÄÑ ¸¶¾àÀ» »ç¿ëÇÏÁö ¾Ê°í´Â Á¤»óÀûÀÎ »ýȰÀ» ÇÒ ¼ö ¾ø°Ô µÇ¸ç, Á¾±¹¿¡ °¡¼­´Â À°Ã¼ÀûÀ¸·Î³ª Á¤½ÅÀûÀ¸·Î ÆóÀÎÀÌ µÇ°Ô ÇÏ´Â ¹°ÁúÀÌ´Ù. ÀÌ·± ¹°ÁúÀÌ ÀÇ·á ¹× ¿¬±¸ ÀÌ¿ÜÀÇ ¸ñÀû¿¡ ³²¿ëµÇ´Â À§ÇèÀ» ¹æÁöÇϱâ À§ÇÏ¿© Á¤ÇÑ ¹ý·ü»ó ¿ë¾î°¡ ¸¶¾àÀÌ´Ù. ¸¶¾àÀº ¨ç ¾Þ¼Ó¿¡¼­ äÃëÇÏ´Â ¾ÆÆí ¾ËÄ®·ÎÀ̵å°è ¸¶¾à
  • narcotic intoxication
    ¸¶¾à Áßµ¶
    ¸¶Ã볪 ½À°ü¼º Ž´Ð ÀÛ¿ëÀÌ ÀÖ´Â ¾àÁ¦, Áï ¸¶¾àÀÇ »ó¿ë¿¡ ÀÇÇÑ Áßµ¶. ÀϹÝÀûÀ¸·Î °ü¼º Áßµ¶À» ¸»ÇÑ´Ù. ¸¶¾àÀº ¹Ì·®À¸·Î ÁøÅë, ¸¶Ãë ÀÛ¿ëÀ» Çϰí, ½À°ü¼º°ú Ž´Ð¼ºÀ» °¡Á®¿Í »ç¿ëÀ» ÁßÁöÇÏ¸é ½ÉÇÑ ±Ý´Ü Áõ»óÀ» ÀÏÀ¸Å°¸ç, ¶Ç ³²¿ëÇÒ ¿°·Á°¡ ÀÖ´Â ¾à¹°·Î¼­ 1830³â ȣĪÀÌ ¡®¸¶¾à¡¯À¸·Î ÅëÀϵǾú´Ù. ¸¶¾àÀº ¨ç ¾Þ¼Ó¿¡¼­ äÃëÇÏ´Â ¾ÆÆí ¾ËÄ®·ÎÀ̵å°è ¸¶¾à
  • narcotic lung
    ¸¶¾à¼º Æó
  • 5-HT1 receptor antagonist
    5-HT1 ¼ö¿ë±â ±æÇ×Á¦
    ÀÏÂïÀÌ 5-hydroxytry
  • alpha adrenergic antagonist
    ¾ËÆÄ ¾Æµå·¹³¯¸° ±æÇ×Á¦
  • antagonist
    ±æÇ×Á¦, ±æÇ× ¹°Áú, ±æÇ×±Ù, ±æÇ× ¾à
    ¹Ý´ë¾î=agonist. µ¿±Ù±ºÀ̳ª ÁÖµÈ ¿îµ¿±Ù¿¡ ¹Ý´ëµÇ´Â ±â´ÉÀ» ÇÏ´Â ±ÙÀ°. ¾à¸®Çп¡¼­´Â ´Ù¸¥ ¾à¹°ÀÇ È¿´ÉÀ» °¨¼Ò½ÃŰ´Â ¾à¹°À̳ª µ¿ÀÏÇÑ ¼ö¿ë±â¸¦ ÀÚ±ØÇÏ¿© »ý¼ºÇÏ´Â ¹°ÁúÀ» ÀǹÌÇÑ´Ù. ´Ù¸¥ ¾à¹°, ¹°ÁúÀÇ ÀÛ¿ëÀ» »ý¹°ÇÐÀû ¹ÝÀÀÀ» À¯µµÇÏÁö ¾Ê°í ¼¼Æ÷ ¸®¼ÁÅÍ¿¡ °áÇÕÇÏ¿©, °¨¾à ¶Ç´Â ¹«È¿·Î ÇÏ´Â ¾à¹°, ¹°Áú.
  • antagonist tooth
    ´ëÇÕÄ¡
  • competitive antagonist
    °æÀï ±æÇ× ¹°Áú
  • enzymic antagonist
    È¿¼Ò ±æÇ×Á¦
  • folic acid antagonist
    ¿±»ê ±æÇ×Á¦
  • hormone antagonist
    Ç×È£¸£¸ó ¾à, Ç×È£¸£¸ó ¹°Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
analgesics, non-narcotic Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the controlled substances act.
(12 Dec 1998)
narcotic 1. Pertaining to or producing narcosis.
2. <pharmacology> An agent that produces insensibility or stupor, applied especially to the opioids, i.e. To any natural or synthetic drug that has morphine like actions.
Origin: Gr. Narkotikos = benumbing, deadening
(18 Nov 1997)
narcotic analgesic agent <pharmacology> Medications that relieve pain but have addictive potential if used regularly.
Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin.
(27 Sep 1997)
narcotic analgesics <pharmacology> Medications that relieve pain but have addictive potential if used regularly.
Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin.
(27 Sep 1997)
narcotic antagonists Agents inhibiting the effect of narcotics on the central nervous system.
(12 Dec 1998)
narcotic blockade The use of drugs to inhibit the effects of narcotic substances, as with naloxone.
(05 Mar 2000)
narcotic hunger The physiological craving for narcotics.
(05 Mar 2000)
narcotic reversal The use of narcotic antagonists, such as naloxone, to terminate the action of narcotics.
(05 Mar 2000)
drug and narcotic control Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (drug approval), and marketing of drugs.
(12 Dec 1998)
aldosterone antagonist An agent that opposes the action of the adrenal hormone aldosterone on renal tubular mineralocorticoid retention; these agents, e.g., spironolactone, are useful in treating the hypertension of primary hyperaldosteronism, or the sodium retention of secondary hyperaldosteronism.
(05 Mar 2000)
antagonist <pharmacology> A substance that tends to nullify the action of another, as a drug that binds to a cell receptor without eliciting a biological response.
Origin: Gr. Antagonistes = an opponent
(18 Nov 1997)
associated antagonist One of two muscles or groups of muscles which pull in nearly opposite directions, but which, when acting together, move the part in a path between their diverging lines of action.
(05 Mar 2000)
beta-adrenoreceptor antagonist A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable.
Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker.
(05 Mar 2000)
calcium antagonist calcium channel-blocking agent
calcium channel antagonist <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • narcotic
    ¸¶Ãë¾àÀÇ;¸¶Ã뼺ÀÇ;Ãָ鼺ÀÇ;(Ã¥À̾߱âµîÀÌ)ÀáÀÌ ¿À´Â;Á¹¸®´Â;¸¶¾àÀÇ ¸¶¾à»ç¿ëÀÇ;¸¶¾à»ó¿ëÀÚÀÇ;ÃÖ¸é¾à;¸¶Ãë¾à(¸¶¾à)(Áßµ¶ÀÚ)
  • antagonist
    Àû´ë
  • antagonist
    Àû´ëÀÚ;´ë¸³ÀÚ
  • treatment
    Ãë±Þ
  • Pasteur treatment
    ±¤°ßº´ ¿¹¹æ Á¢Á¾
  • heat treatment
    ¿­Ã³¸®
  • medical treatment
    (³»°úÀû)Ä¡·á
  • national treatment
    (¿Ü±³)³»±¹¹Î ´ë¿ì
  • pneumothorax treatment
    ±âÈä¼ú
  • preferential treatment
    ¿ì´ë
  • treatment
    ó¸®;°¡°ø;´ë¿ì;´ëÁ¢;(ÀÇ»çÀÇ)Ä¡·á(¹ý);Ä¡·áÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á